Replies to post #115978 on Biotech Values

[DewDiligence]

Quiz—Merck stopped testing its top acquisition from its merger with Schering Plough, a blood thinner that caused dangerous amounts of bleeding.

Yes, this is a misstatement insofar as MRK continued testing on a subset of patients in one of the two Vorapaxar trials. However, the answer to the quiz is a more serious misstatement.